Healthcare & Life Sciences
Yellow Jersey Therapeutics
Switzerland
series-c-plus
series-c-plus
Stage
2
Investors
About
Yellow Jersey Therapeutics is a biotechnology spinoff from Numab Therapeutics focused on developing novel therapeutic antibodies.
Explore Yellow Jersey Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.